Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Opioid Use DisorderPregnancy Related
Interventions
DRUG

Buprenorphine/ Methadone exposure

Validate candidate genes- and prenatal opioid exposure- related maternal relapse and NOWS outcome associations in pregnant women and their newborns.

Trial Locations (1)

15213

RECRUITING

UPMC Magee-Womens Hospital, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

OpalGenix, Inc

INDUSTRY

lead

Ilana Hull

OTHER